Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Mirjana Tadic-Ovcina"'
Autor:
Fieke W. Hoff, Stephen S. Chung, Prapti A. Patel, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Selamawit Yohannes, Jaime Shahan, Hetalkumari Patel, Praveen Ramakrishnan Geethakumari, Madhuri Vusirikala, Robert H. Collins, Yazan F. Madanat
Publikováno v:
Transplant Immunology. 77:101808
Autor:
Fieke W. Hoff, Prapti A. Patel, Stephen S. Chung, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Jaime Shahan, Courtney Dryden, Hetalkumari Patel, Afrough Aimaz, Praveen Ramakrishnan Geethakumari, Robert H. Collins, Madhuri Vusirikala, Yazan F. Madanat
Publikováno v:
Blood. 140:4749-4750
Autor:
Prapti A. Patel, Ankit Kansagra, Madhuri Vusirikala, Yazan F. Madanat, Stephen Chung, Abeer AhmedRabie, Mirjana Tadic-Ovcina, Robert H. Collins, Praveen Ramakrishnan, Courtney Dryden, Jaime Lynn Shahan
Publikováno v:
Transplantation and Cellular Therapy. 27:S97-S98
Autor:
Jude Khatib, Yazan F. Madanat, Courtney Dryden, Steven Chung, Ankit Kansagra, Abeer AhmedRabie, Robert H. Collins, Debra Helton, Jingsheng Yan, Jaime Lynn Shahan, Hetalkumari Patel, Madhuri Vusirikala, Praveen Ramakrishnan, Prapti A. Patel, Mirjana Tadic-Ovcina, Alisa White, Chul Ahn
Publikováno v:
Transplantation and Cellular Therapy. 27:S142-S143
Autor:
Robert Brian Berryman, Edward Agura, Barry Cooper, Mirjana Tadic-Ovcina, Houston Holmes, Giovanna Saracino, Estil Vance, Sandy Li, Christopher Maisel, Joseph Fay
Publikováno v:
The oncologist. 16(2)
Purpose. To determine the efficacy and safety of clofarabine and cytarabine (Ara-C) in adult patients with relapsed or refractory acute myeloid leukemia (AML) and in elderly patients with untreated AML and heart disease. Patients and Methods. Patient
Publikováno v:
Biology of Blood and Marrow Transplantation. 14(2)
Publikováno v:
Blood. 110:4954-4954
BACKGROUND: Allogeneic transplantation, a treatment previously reserved only for healthy younger patients, can be modified by reducing the intensity and toxicity of the chemotherapy regimens, to allow older patients to receive this treatment safely.
Autor:
Christopher Maisel, Giovanna Saracino, Barry Cooper, Houston Holmes, E.A. Vance, R. Brian Berryman, Andrew De Leon, Arturo Molina, Edward Agura, Joseph W. Fay, Mirjana Tadic-Ovcina, L. Pineiro, Laura Brougher
Publikováno v:
Blood. 108:1951-1951
PURPOSE: To evaluate the efficacy and safety of clofarabine, a novel deoxyadenosine analog, in adult patients with refractory or relapsed acute myeloid leukemia and in selected elderly patients with untreated AML and heart disease. PATIENTS AND METHO
Autor:
R.G. Woelfel, Edward Agura, R.B. Berryman, V. Estil, P. Luis, Mirjana Tadic-Ovcina, Joseph W. Fay
Publikováno v:
Biology of Blood and Marrow Transplantation. (2):S280
BACKGROUND: Allogeneic transplantation, a treatment previously reserved only for healthy younger patients, can be modified by reducing the intensity and toxicity of the chemotherapy regimens, to allow older patients to receive this treatment safely.